Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × veliparib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Glioblastoma 2 Thrombocythemia, Essential 1 Testicular Neoplasms 1 Renal Insufficiency 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1 Melanoma 1 Lung Neoplasms 1 Liver Failure 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Cyclophosphamide 7 Biopsy 5 mogamulizumab 3 fludarabine 3 Specimen Handling 3 ruxolitinib 2 hypericin 2 fludarabine phosphate 2 Vincristine 2 Prednisone 2 Nivolumab 2 Mycophenolic Acid 2 Magnetic Resonance Spectroscopy 2 Immunoglobulin G 2 Disulfides 2 Brentuximab Vedotin 2 tofacitinib 1 tazemetostat 1 talimogene laherparepvec 1 sodium-iodide symporter 1 romidepsin 1 cemiplimab 1 cc-486 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Valganciclovir 1 Transplantation 1 Therapeutics 1 Tacrolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡